First Patient Treated in Innovative Clinical Study ‘Amelia-1’, Testing the Novel Investigational Drug Evexomostat Plus a PI3K Inhibitor in Late-Stage Breast Cancer Patients
Ameliaâ„¢-1 Study is testing if evexomostat can improve patients' safety and clinical response to a PI3K inhibitor plus an estrogen receptor degrader. Evexomostat, a novel...
Exeliom Biosciences Announces First Patient Enrolled in Phase 1 Study for the Maintenance in Remission in Adult Patients With Mild to Moderate Crohn’s Disease
Exeliom Biosciences, a biotechnology company, announced today the enrollment of the first patient in its Phase 1 clinical study of an investigational oral single-strain microbiome...